Monday 1 November 2010

Catalogue details human- and animal-based research material portfolios

Sera Laboratories International Ltd (Sera Lab), the serum specialist, has launched a new BioProducts catalogue presenting its extensive range of animal and human material, disease state material and the new range of Human Tissues.

Animal control material is collected from colonies of drug naïve animals under veterinary supervision. Human control material is collected from FDA registered facilities and is fully viral tested to current FDA regulations.


Sera Lab retains a comprehensive inventory of disease state material sourced from clinical diagnostic laboratories as remnant specimens. Samples may also be collected prospectively using existing IRB permits. Human Tissues are collected at registered facilities in the US from both normal and disease state donors and are shipped directly to the end user.

The newly available BioProducts catalogue from Sera Lab gives details of one of Europe’s largest ranges of biological products for use in life science research and drug discovery applications. To ensure rapid delivery times, a comprehensive inventory of more frequently requested samples listed within the catalogue is retained, whilst more esoteric material is collected to order by Sera Lab.


Sera Lab